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ABSTRACT 
 
Autism spectrum disorder (ASD) is a complex and heterogeneous 
neurodevelopmental disorder. In addition to the core symptoms of ASD, many patients with 
ASD also show comorbid gut dysbiosis, which may lead to various gastrointestinal (GI) 
problems. Intriguingly, there is evidence that gut microbiota communicate with the central 
nervous system to modulate behavioral output through the gut-brain axis. Although many 
studies have reported differences in microbiota between patients with ASD and control 
subjects, no particular gut bacteria species is currently implicated in ASD. Based on the 
emerging link between gut microbiota and ASD and the lack of consensus on specific 
causative gut bacteria, we aimed to investigate the microbiota composition in a mouse model 
of ASD and to identify the specific microbiota community involved in ASD-related 
behavioral symptoms. In this study we performed a 16s rRNA gene-based metagenomics 
analysis in an ASD mouse model. Here, we focused on a model mouse with human 15q11-13 
duplication (15q dup), the most frequent chromosomal aberration or copy number variation 
(CNV) found in ASD.  
Metagenomic analysis revealed that microbiome species richness was significantly 
decreased in 15q dup mice. No differences were found in microbiota relative abundances in 
phylum and genus level between WT and 15q dup mice. However, in species level, 13 OTUs 
were more abundant in WT mice, among which 7 OTUs were not detected in 15q dup mice. 
Combination of 4 weeks antibiotics treatment of ampicillin or neomycin followed by 
behavioral analysis showed that neomycin improved USV call number in 15q dup mice. 
However, the antibiotics treatment didn’t affect locomotor activity and anxiety-like behavior 
in any mice. Metagenomic analysis after antibiotics treatment and behavioral test showed 
an increase in species richness in 15q dup mice treated with neomycin but not in WT, as 
shown by OTUs number, Chao1, and ACE index. UniFrac-PCoA also suggested differences 
in microbiota composition between WT and 15q dup mice after neomycin treatment. In 15q 
dup mice, neomycin increased the relative abundance of Bacteroides and Parabacteroides 
and decreased that of Parasutterella. But in WT, neomycin increased the relative abundance 
of Roseburia and Oscillibacter but decreased that of Lactobacillus. In species level, 6 OTUs 
which included Barnesiella viscericola, Clostridium hathewayi, Oscillibacter valericigenes, 
Prevotella sp. Smarlab 121567, Clostridium clostridioforme, Hydrogenoanaerobacterium 
saccharovorans, and Roseburia inulinivorans were more abundant in 15q dup mice treated 
with neomycin. Moreover, these 6 OTUs are included in the 13 OTUs that were more 
abundant in WT. These findings suggest that neomycin treatment in 15q dup mice altered 
the microbiota composition in favors of the growth of bacteria with beneficial effect on USV 
call number. 
Most of these candidates of beneficial OTUs belong to Clostridium clusters XIVa 
and IV. Clostridium hathewayi, Clostridium clostridioforme, and Roseburia inulinivorans 
belong to Clostridium cluster XIVa, while Oscillibacter valericigenes and 
Hydrogenoanaerobacterium saccharovorans belong to Clostridium cluster IV. Clostridium 
clusters XIVa and IV are known for their anti-inflammatory properties and also abundantly 
produce short chain fatty acids (SCFAs), including butyrate, propionate, and acetate. SCFAs 
may regulate brain function through many pathways, including inhibition of histone 
deacetylase and modulation of 5-HT. 5-HT signaling itself has been associated with USV. 
Given that the beneficial OTUs identified in this study are SCFA-producing species with the 
described properties, it is possible that these bacteria are capable of modulating 5-HT levels, 
thereby affecting USV.  
Although further studies using human samples or germ-free mice conventionalized 
with the candidate of beneficial OTUs are required to confirm our results, the findings 
presented in this study suggest that beneficial OTUs which produce SCFAs, may enhance 
USV in the 15q dup mouse model of ASD. 
